| payload |
{"created_at":"2026-04-10T14:13:04.518 {"created_at":"2026-04-10T14:13:04.518445+00:00","dedupe_key":"signal_enriched:discovery_ipo_delta:f95d600c9b1b14df","evidence_event_ids":["evt_b4649cfa2859"],"signal_type":"discovery_ipo_delta","source":"discovery_ingestor","value":{"aggregator_url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPaXV3dmllSGRadHFoSXYyT19WZEY0N3BoNkdtbFJsWi16WTR6TE0wREdJWXlPTjlaQU1IbVJHUnc1NDgyVEdBdC0xRHc2NUNfLXczRGtoWTRURi1ocDQ4SnEyUThaOVNnek1CcjNCaTRKNGV1Mm1RRUY4cVpPYzBDWTZ6OEhZSU9WUENOZFZMMENDeEdOaWZDRzViaG95RUhjZE9zbDR2WTRRMnpxWTkw?oc=5","as_of":"2026-04-10T14:13:04.518445+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPaXV3dmllSGRadHFoSXYyT19WZEY0N3BoNkdtbFJsWi16WTR6TE0wREdJWXlPTjlaQU1IbVJHUnc1NDgyVEdBdC0xRHc2NUNfLXczRGtoWTRURi1ocDQ4SnEyUThaOVNnek1CcjNCaTRKNGV1Mm1RRUY4cVpPYzBDWTZ6OEhZSU9WUENOZFZMMENDeEdOaWZDRzViaG95RUhjZE9zbDR2WTRRMnpxWTkw?oc=5","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_1b0db5f8fe814798","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-10T14:23:12.307372+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPaXV3dmllSGRadHFoSXYyT19WZEY0N3BoNkdtbFJsWi16WTR6TE0wREdJWXlPTjlaQU1IbVJHUnc1NDgyVEdBdC0xRHc2NUNfLXczRGtoWTRURi1ocDQ4SnEyUThaOVNnek1CcjNCaTRKNGV1Mm1RRUY4cVpPYzBDWTZ6OEhZSU9WUENOZFZMMENDeEdOaWZDRzViaG95RUhjZE9zbDR2WTRRMnpxWTkw?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"gstatic.com","publisher_resolution":"canonical_aggregator_unresolved","requested_url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPaXV3dmllSGRadHFoSXYyT19WZEY0N3BoNkdtbFJsWi16WTR6TE0wREdJWXlPTjlaQU1IbVJHUnc1NDgyVEdBdC0xRHc2NUNfLXczRGtoWTRURi1ocDQ4SnEyUThaOVNnek1CcjNCaTRKNGV1Mm1RRUY4cVpPYzBDWTZ6OEhZSU9WUENOZFZMMENDeEdOaWZDRzViaG95RUhjZE9zbDR2WTRRMnpxWTkw?oc=5","source_event_id":"evt_b4649cfa2859","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"a382476552955041","kind":"ipo_calendar","published_at":"2026-04-10T13:13:27+00:00","publisher_domain":"gstatic.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.35,"dates_mentioned":[],"entities":[{"asset_class":"","name":"Pharma Voice","relevance":"high","symbol":"","type":"publisher"},{"asset_class":"","name":"Trump","relevance":"medium","symbol":"","type":"person"}],"event_type":"listing","information_gaps":["No article text content (beyond CSS/HTML) was provided, so IPO timing, companies involved, and any tariff mechanism/details are not available.","No measurable claims (e.g., number of IPOs, dates, dollar amounts, tariff rates) are present in the provided text.","No confirmation of whether the \u201ctariff loophole\u201d is factual, specific, or currently in effect\u2014only the headline framing is available."],"key_facts":["Headline states: \u201cBiotech\u2019s IPO comeback; Trump\u2019s tariff loophole for pharma - Pharma Voice.\u201d","Source summary repeats the same two themes: biotech IPO comeback and a Trump tariff loophole for pharma."],"numeric_claims":[],"primary_claim":"Biotech is experiencing an IPO comeback, and Trump\u2019s tariff policy contains a loophole for pharma (as reported by Pharma Voice).","relevance_score":0.45,"sentiment":"mixed","source_quality":"high","summary":"The signal claims that biotech is seeing an IPO \u201ccomeback,\u201d and that Trump\u2019s tariff policy includes a \u201cloophole\u201d benefiting pharma. No article body details were provided to verify specifics.","topics":["biotech IPO","tariffs","pharma policy","Trump tariff loophole"]},"source":"Pharma Voice","source_domain":"gstatic.com","summary":"Biotech\u2019s IPO comeback; Trump\u2019s tariff loophole for pharma Pharma Voice","tickers":[],"title":"Biotech\u2019s IPO comeback; Trump\u2019s tariff loophole for pharma - Pharma Voice","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp"}}... |